Anticoagulation in elderly patients at high risk of atrial fibrillation without documented arrhythmias

Recent studies have suggested that patients with high CHA2DS2VASc-score [Congestive Heart failure, hyperten- sion, Age ≥ 75 years （doubled）, Diabetes, Stroke （doubled）, Vascular disease, Age 65-74 years, Sex category （female sex）] thromboembolic complications occurred irrespective of the presence of...

Full description

Saved in:
Bibliographic Details
Published inJournal of geriatric cardiology : JGC Vol. 14; no. 3; pp. 166 - 168
Main Author Manuel Martinez-Selles Eusebio Garcia-Izquierdo Jaen Ignacio Fernandez Lozano
Format Journal Article
LanguageEnglish
Published China Science Press 01.03.2017
Subjects
充血性心力衰竭
心律失常
患者
房颤
抗凝
治疗
老年
血管疾病
Interatrial block
Anticoagulation
Prognosis
Atrial fibrillation
Online AccessGet full text

Cover

More Information
Summary:Recent studies have suggested that patients with high CHA2DS2VASc-score [Congestive Heart failure, hyperten- sion, Age ≥ 75 years （doubled）, Diabetes, Stroke （doubled）, Vascular disease, Age 65-74 years, Sex category （female sex）] thromboembolic complications occurred irrespective of the presence of atrial fibrillation （AF） and anticoagulant therapy may be initiated irrespective of documented AF.
Bibliography:Recent studies have suggested that patients with high CHA2DS2VASc-score [Congestive Heart failure, hyperten- sion, Age ≥ 75 years （doubled）, Diabetes, Stroke （doubled）, Vascular disease, Age 65-74 years, Sex category （female sex）] thromboembolic complications occurred irrespective of the presence of atrial fibrillation （AF） and anticoagulant therapy may be initiated irrespective of documented AF.
Anticoagulation; Atrial fibrillation; Interatrial block; Prognosis
11-5329/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1671-5411
DOI:10.11909/j.issn.1671-5411.2017.03.004